Companies / Ionis Pharmaceuticals Inc / Activity
Activity — Ionis Pharmaceuticals Inc
77 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | Schneider Eugene Executive | Sell | Common Stock | $412.5K | -6K -8.34% | 63,890 0.04% of shares | medium |
| Jan 2, 2026 | Swayze Eric Executive | Sell | Common Stock | $402.7K | -5K -14.41% | 30,453 0.02% of shares | medium |
| Mar 3, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $402.4K | -5K -17.76% | 23,296 0.01% of shares | medium |
| Apr 15, 2026 | Parshall B Lynne Director | Sell | Common Stock | $340.3K | -4K -7.93% | 51,878 0.03% of shares | medium |
| Mar 3, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $325.1K | -4K -9.02% | 41,317 0.02% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $324.0K | -4K -17.96% | 17,494 0.01% of shares | medium |
| Jan 22, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $323.5K | -4K -15.00% | 22,541 0.01% of shares | medium |
| Jan 16, 2026 | Kordasiewicz Holly B. Executive | Sell | Common Stock | $313.3K | -4K -21.96% | 14,718 <0.01% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $292.8K | -3K -16.51% | 17,494 0.01% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $179.3K | -2K -10.72% | 17,494 0.01% of shares | medium |
| Apr 1, 2026 | Klein Joseph III Director | Sell | Common Stock | $168.3K | -2K -16.75% | 11,014 <0.01% of shares | medium |
| Mar 3, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $167.9K | -2K -32.27% | 4,383 <0.01% of shares | medium |
| Jan 16, 2026 | Jenne Kyle Executive | Sell | Common Stock | $138.5K | -2K -10.01% | 16,389 <0.01% of shares | medium |
| Mar 9, 2026 | Monia Brett P CEO | Sell | Common Stock | $127.3K | -2K -0.69% | 242,662 0.15% of shares | medium |
| May 1, 2026 | Klein Joseph III Director | Sell | Common Stock | $106.5K | -1K -11.50% | 11,014 <0.01% of shares | medium |
| Jan 16, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $87.1K | -1K -19.41% | 4,772 <0.01% of shares | low |
| Mar 3, 2026 | Klein Joseph III Director | Sell | Common Stock | $81.8K | -1K -8.42% | 11,014 <0.01% of shares | low |
| Mar 3, 2026 | Diaz Allene M. Director | Sell | Common Stock | $81.2K | -1K -20.87% | 3,811 <0.01% of shares | low |
| Mar 3, 2026 | Loscalzo Joseph Director | Sell | Common Stock | $66.8K | -832 -2.24% | 36,330 0.02% of shares | low |
| Mar 3, 2026 | Bennett C Frank Executive | Sell | Common Stock | $64.8K | -802 -0.99% | 80,554 0.05% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $61.0K | -755 -3.24% | 22,541 0.01% of shares | low |
| Apr 15, 2026 | Parshall B Lynne Director | Sell | Common Stock | $41.1K | -534 -1.03% | 51,344 0.03% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $19.0K | -238 -5.19% | 4,347 <0.01% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $16.1K | -201 -4.42% | 4,347 <0.01% of shares | low |
| Mar 4, 2026 | Loscalzo Joseph Director | Sell | Common Stock | $16.0K | -200 -0.55% | 36,330 0.02% of shares | low |
| Jan 16, 2026 | Swayze Eric Executive | Sell | Common Stock | $3.7K | -49 -13.35% | 318 <0.01% of shares | low |
| Mar 3, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $2.9K | -36 -0.82% | 4,347 <0.01% of shares | low |